Selected Grants
Evaluation of a Soft Tissue Biopsy System for Trans-Rectal and Trans-Perineal Biopsy of the Prostate
Clinical TrialPrincipal Investigator · Awarded by URO-1 Inc. · 2023 - 2028VAPOR 2 Study
Clinical TrialPrincipal Investigator · Awarded by Francis Medical, Inc. · 2023 - 2028Angiodynamics NanoKnife Study
Clinical TrialPrincipal Investigator · Awarded by Angiodynamics · 2022 - 2025Image guided targeted biopsy of clinically significant prostate cancer with acoustic radiation force
ResearchCo Investigator · Awarded by National Institutes of Health · 2010 - 2023Development of a combined ARFI/SWEI ultrasound elasticity imaging system for targeted prostate biopsy guidance
FellowshipCo-Sponsor · Awarded by National Institutes of Health · 2021 - 2023Evaluation of a Soft Tissue Biopsy System for Trans-Rectal and Trans-Perineal Biopsy of the Prostate
Clinical TrialPrincipal Investigator · Awarded by URO-1 Inc. · 2023 - 2028VAPOR 2 Study
Clinical TrialPrincipal Investigator · Awarded by Francis Medical, Inc. · 2023 - 2028Angiodynamics NanoKnife Study
Clinical TrialPrincipal Investigator · Awarded by Angiodynamics · 2022 - 2025Image guided targeted biopsy of clinically significant prostate cancer with acoustic radiation force
ResearchCo Investigator · Awarded by National Institutes of Health · 2010 - 2023Development of a combined ARFI/SWEI ultrasound elasticity imaging system for targeted prostate biopsy guidance
FellowshipCo-Sponsor · Awarded by National Institutes of Health · 2021 - 2023An Extension Study of MRI/US Fusion Imaging and Biopsy in Combination with Nanoparticle Directed Focal Therapy for Ablation of Prostate Tissue
Clinical TrialPrincipal Investigator · Awarded by Nanospectra Biosciences, Inc. · 2020 - 2023Early Detection of Clinically Significant Prostate Cancer using Ultrasonic Acoustic Radiation Force Impulse (ARFI) Imaging
ResearchCo Investigator · Awarded by United States Army Medical Research Acquisition Activity · 2016 - 2019Prospective registry to optimize clinical care (DUCIMAS)
ResearchPrincipal Investigator · Awarded by Myriad Genetics, Inc. · 2016 - 2019A Phase 3 Study to Evaluate the Safety and Efficacy of Tc-MIP-1404 SPECT/CT Imaging to Detect Clinically Significant Prostate Cancer in Men with Biopsy Proven Low-Grade Prostate Cancer who are Candidates for Active Surveillance(proSPECT-AS)
Clinical TrialPrincipal Investigator · Awarded by Molecular Insight Pharmaceuticals, Inc. · 2016 - 2019A Pilot Study in Human Subjects Evaluating the Use of the NanoKnife System for Ablation of Prostate Cancer Tissue in a Low Risk Patient Population
Clinical TrialPrincipal Investigator · Awarded by AngioDynamics · 2014 - 2018Prostate Cancer Assessment and Treatment Guidance Via Integrated 3D ARFI Elasticity Imaging and Multi-Parametric MRI
ResearchCo Investigator · Awarded by Kitware Inc. · 2015 - 2016Evaluation of Sexual Function after Primary and Salvage Prostate Cryoablation for Localized Prostate Cancer
ResearchPrincipal Investigator · Awarded by Josiah Charles Trent Memorial Foundation · 2010 - 2011Trent Foundation Grant
ResearchPrincipal Investigator · Awarded by Josiah Charles Trent Memorial Foundation · 2006 - 2009Psychobiology of male sexual dysfunction following treatment of prostate cancer
ResearchPrincipal Investigator · Awarded by Josiah Charles Trent Memorial Foundation · 2002 - 2003External Relationships
- AngioDynamic
- Astellas Pharma Inc.
- Ferring Pharmaceuticals
- Francis Medical
- Janssen Pharmaceuticals (Johnson & Johnson)
- AngioDynamic
- Astellas Pharma Inc.
- Ferring Pharmaceuticals
- Francis Medical
- Janssen Pharmaceuticals (Johnson & Johnson)
- Merck Sharpe & Dohme (Merck & Co, USA)
This faculty member (or a member of their immediate family) has reported outside activities with the companies, institutions, or organizations listed above. This information is available to institutional leadership and, when appropriate, management plans are in place to address potential conflicts of interest.